CN112690335A - Defaecation and sleep aiding goat milk powder containing lavender extract and preparation method thereof - Google Patents
Defaecation and sleep aiding goat milk powder containing lavender extract and preparation method thereof Download PDFInfo
- Publication number
- CN112690335A CN112690335A CN202011560765.2A CN202011560765A CN112690335A CN 112690335 A CN112690335 A CN 112690335A CN 202011560765 A CN202011560765 A CN 202011560765A CN 112690335 A CN112690335 A CN 112690335A
- Authority
- CN
- China
- Prior art keywords
- sleep
- milk powder
- goat milk
- lavender extract
- aiding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 90
- 235000020251 goat milk Nutrition 0.000 title claims abstract description 65
- 235000020723 lavender extract Nutrition 0.000 title claims abstract description 62
- 229940083980 lavender extract Drugs 0.000 title claims abstract description 59
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 20
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000007872 degassing Methods 0.000 claims abstract description 10
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 241000186315 Lactobacillus paracasei N1115 Species 0.000 claims description 18
- 239000008141 laxative Substances 0.000 claims description 18
- 230000002475 laxative effect Effects 0.000 claims description 18
- 238000001914 filtration Methods 0.000 claims description 15
- 239000000706 filtrate Substances 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 12
- 230000001580 bacterial effect Effects 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 230000002040 relaxant effect Effects 0.000 claims description 10
- 238000001694 spray drying Methods 0.000 claims description 9
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 8
- 244000178870 Lavandula angustifolia Species 0.000 claims description 8
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims description 8
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 8
- 239000001102 lavandula vera Substances 0.000 claims description 8
- 235000018219 lavender Nutrition 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 7
- 241000186000 Bifidobacterium Species 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 5
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 4
- 238000007873 sieving Methods 0.000 claims description 4
- 241001134770 Bifidobacterium animalis Species 0.000 claims description 3
- 229940118852 bifidobacterium animalis Drugs 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 229920001100 Polydextrose Polymers 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 239000002131 composite material Substances 0.000 claims description 2
- 235000021552 granulated sugar Nutrition 0.000 claims description 2
- 230000010355 oscillation Effects 0.000 claims description 2
- 235000013856 polydextrose Nutrition 0.000 claims description 2
- 229940035035 polydextrose Drugs 0.000 claims description 2
- 239000001259 polydextrose Substances 0.000 claims description 2
- 239000008176 lyophilized powder Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 235000013336 milk Nutrition 0.000 abstract description 15
- 239000008267 milk Substances 0.000 abstract description 15
- 210000004080 milk Anatomy 0.000 abstract description 15
- 230000002195 synergetic effect Effects 0.000 abstract description 7
- 238000000605 extraction Methods 0.000 abstract description 5
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 230000035622 drinking Effects 0.000 abstract description 2
- 230000007413 intestinal health Effects 0.000 abstract description 2
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- 230000035764 nutrition Effects 0.000 abstract description 2
- 230000001502 supplementing effect Effects 0.000 abstract description 2
- 241000186605 Lactobacillus paracasei Species 0.000 abstract 1
- 235000013361 beverage Nutrition 0.000 abstract 1
- 230000001914 calming effect Effects 0.000 abstract 1
- 210000000936 intestine Anatomy 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 210000005036 nerve Anatomy 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 33
- 238000002474 experimental method Methods 0.000 description 29
- 206010010774 Constipation Diseases 0.000 description 23
- 239000000976 ink Substances 0.000 description 20
- 239000013641 positive control Substances 0.000 description 15
- 210000003608 fece Anatomy 0.000 description 11
- 210000001035 gastrointestinal tract Anatomy 0.000 description 11
- 230000004620 sleep latency Effects 0.000 description 11
- 230000004622 sleep time Effects 0.000 description 11
- 210000000813 small intestine Anatomy 0.000 description 11
- 241000699666 Mus <mouse, genus> Species 0.000 description 9
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 9
- 239000012153 distilled water Substances 0.000 description 8
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 8
- 230000013872 defecation Effects 0.000 description 7
- 238000003304 gavage Methods 0.000 description 7
- 229960002275 pentobarbital sodium Drugs 0.000 description 7
- 235000013350 formula milk Nutrition 0.000 description 6
- 230000002496 gastric effect Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 239000007924 injection Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229960000796 barbital sodium Drugs 0.000 description 4
- FTOAOBMCPZCFFF-UHFFFAOYSA-N barbitone sodium Natural products CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 4
- 229940125717 barbiturate Drugs 0.000 description 4
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- RGHFKWPGWBFQLN-UHFFFAOYSA-M sodium;5,5-diethylpyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].CCC1(CC)C([O-])=NC(=O)NC1=O RGHFKWPGWBFQLN-UHFFFAOYSA-M 0.000 description 4
- 206010016100 Faeces discoloured Diseases 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 229940099352 cholate Drugs 0.000 description 3
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 230000010412 perfusion Effects 0.000 description 3
- 230000008855 peristalsis Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000028527 righting reflex Effects 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 230000009471 action Effects 0.000 description 2
- -1 compound diphenoxylate Chemical class 0.000 description 2
- 229960004192 diphenoxylate Drugs 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000000147 hypnotic effect Effects 0.000 description 2
- 230000001050 lubricating effect Effects 0.000 description 2
- 238000009629 microbiological culture Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229960001412 pentobarbital Drugs 0.000 description 2
- 230000002572 peristaltic effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000001624 sedative effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical class [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000036578 sleeping time Effects 0.000 description 1
- MHQHHBYRYFICDV-UHFFFAOYSA-M sodium;pyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].O=C1CC(=O)[N-]C(=O)N1 MHQHHBYRYFICDV-UHFFFAOYSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Images
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention belongs to the field of adult milk powder, and discloses a bowel-relaxing sleep-aiding goat milk powder containing lavender extracts and a preparation method thereof. According to the preparation method, the mutton smell of goat milk powder is reduced through steps of degassing and the like, the extraction rate of the lavender extract is improved through secondary extraction of the lavender extract, and the added lavender extract is matched with other components to remove the mutton smell and achieve a good nerve calming effect; the synergistic effect among lactobacillus paracasei, gamma-aminobutyric acid and lavender extracts is utilized, so that the effects of moistening intestines and helping sleep are good, and the beverage is suitable for long-term drinking; the milk powder is used for supplementing nutrition, regulating intestinal health and improving sleep after being eaten.
Description
Technical Field
The invention belongs to the field of formula milk powder, and relates to bowel relaxing and sleep aiding milk powder, in particular to bowel relaxing and sleep aiding goat milk powder containing lavender extracts and a preparation method thereof.
Background
The compendium of materia Medica records: goat milk is sweet, warm and nontoxic, and can benefit five internal organs, tonify kidney deficiency, replenish vital essence and qi, nourish heart and lung, benefit skin and moisten hair. The goat milk has extremely high nutritive value and the food therapy health care efficacy of strengthening the spleen and stomach. In European and American countries, goat milk drinking is very popular, and the market share of goat milk in some countries even exceeds that of cow milk; in China, due to the difference of dietary habits and tastes, a plurality of consumers do not like the mutton smell of the goat milk, and the goat milk products are fewer compared with the milk products of the eight five-flower family, so that the research on the goat milk product which eliminates the mutton smell of the goat milk and simultaneously keeps the nutritive value and the food therapy health care effect of the goat milk can develop a new market.
According to statistics, the total number of gastrointestinal tract diseases in China is nearly 3 hundred million, wherein constipation is a common disease of modern people which is not negligible, the gastrointestinal tract diseases are frequently related to a fast-paced and high-pressure life style of the modern people, and the high-pressure life style causes insomnia and anxiety, so that the formula milk powder capable of relaxing bowels and assisting sleep is popular to be developed by adjusting a formula and a process method.
The conventional milk powder with the functions of relaxing bowels and assisting sleep is usually milk powder, has a common spleen and stomach strengthening effect, is single in action effect, and only has a good function of relaxing bowels or an outstanding function of assisting sleep, so that the goat milk is selected as a milk source by improving the preparation process, the components and the proportion of the formula of the goat milk powder are adjusted, and the synergistic components are searched.
Disclosure of Invention
The invention aims to provide a defaecation and sleep-aiding goat milk powder containing a lavender extract, which is added with lactobacillus paracasei N1115 powder, gamma-aminobutyric acid and the lavender extract under a synergistic effect so as to achieve the purposes of defaecation and sleep-aiding;
the invention also aims to provide a preparation method of the bowel-relaxing sleep-aiding goat milk powder containing the lavender extract, so as to achieve the purpose of reducing the goat milk smell.
In order to achieve the purpose, the invention adopts the technical scheme that:
a laxative sleep-aiding goat milk powder containing lavender extract comprises the following raw materials of active ingredients in parts by weight:
70-90 parts of raw goat milk powder, 6.5-13.5 parts of polydextrose, 3-10 parts of lactobacillus paracasei N1115 powder, 0.001-0.005 part of gamma-aminobutyric acid, 3-7 parts of white granulated sugar, 1.5-3.5 parts of lavender extract, 0.3-0.8 part of composite essence, 0.2-0.8 part of animal bifidobacterium powder and 0.2-0.8 part of bifidobacterium lactis powder.
As a limitation, the lactobacillus paracasei N1115 powder, the bifidobacterium animalis powder and the bifidobacterium lactis powder are all active freeze-dried powder.
As another limitation, the total number of colonies of the Lactobacillus paracasei N1115 powder is 0.1X 1010～1×1010CFU/g; the total number of bacterial colonies of animal Bifidobacterium powder is 0.1 × 1010～1×1010CFU/g; the total bacterial colony count of the Bifidobacterium lactis powder is 0.1 × 1010～1×1010CFU/g。
The Lactobacillus paracasei N1115(Lactobacillus paracasei N1115) used in the invention is preserved in 17.3.2011 in China general microbiological culture collection center (the national patent office assigned patent microbiological collection center) of China microbiological culture collection management Committee No. 3 of West Lu No. 1 Hospital, the south China area, Beijing, with the preservation number: CGMCC No.4691, which is disclosed in Chinese invention patent with the patent number of 201110357058.8 for the first time;
the lactobacillus paracasei N1115 strain has good acid resistance and cholate resistance, the acid resistance and cholate resistance of the strain are far higher than those of other commercial strains, the strain can be adhered to intestinal epithelial cells of a human body, and the strain is a domestic novel probiotic capable of activating immune cells to enhance the immune regulation effect of an organism.
As a third limitation, the raw goat milk powder is obtained by primary filtering, degassing, secondary filtering and spray drying raw goat milk; the raw materials are obtained by sieving, and the mesh number of the sieve is 110-130 meshes.
Wherein the primary filtration is carried out by adopting a filter; the degassing is carried out by adopting a degassing tank; the secondary filtration is carried out by adopting a duplex filter;
the spray drying is high-pressure spray drying, and the technological parameters are as follows: the pressure of the high-pressure pump is 190-260bar, the air inlet temperature is 150-195 ℃, and the air outlet temperature is 85-95 ℃.
As a further limitation, the mesh number of the primary filter screen is 15-28 meshes; in the degassing process, the vacuum pressure is 85-90 bar, the inlet temperature is 78-82 ℃, and the outlet temperature is 68-72 ℃; the number of the refiltered screens is 20-28 meshes.
As a fourth limitation, the preparation process of the lavender extract comprises the following steps in sequence:
soaking fresh Lavender in water, ultrasonically oscillating, heating at low temperature to boil, standing, and filtering to obtain filtrate and residue;
repeating the above operations on the filter residue to obtain a second filtrate and a second filter residue;
mixing the filtrate with the filtrate of the second time, concentrating, and spray drying to obtain Lavender extract.
As a further limitation, the mass ratio of the fresh lavender to water is 1: 8-12;
the ultrasonic oscillation time is 15-20 min;
the low-temperature heating temperature is 80-90 ℃;
the standing time is 4-6 min;
the mesh number of the filter cloth for filtering is 80-100 meshes.
Wherein the concentration is carried out by heating and concentrating in a water-proof way at 55-65 ℃;
the technological parameters of spray drying are as follows: the pump speed of the peristaltic pump is 290-300 mL/h, the air inlet temperature is 210-225 ℃, and the air exhaust temperature is 85-95 ℃.
The invention also provides a preparation method of the bowel-relaxing sleep-aiding goat milk powder containing the lavender extract, which is characterized in that all the raw materials are uniformly mixed to obtain the bowel-relaxing sleep-aiding goat milk powder containing the lavender extract.
Due to the adoption of the technical scheme, compared with the prior art, the invention has the technical progress that:
(1) the lactobacillus paracasei N1115, the gamma-aminobutyric acid and the lavender extract which are reasonable in proportion are added at the same time, the three are synergistic, the sedative, hypnotic and anticonvulsant effects of the gamma-aminobutyric acid and the sedative effect of the lavender extract are enhanced, and the hypnotic effect is better than that of the lactobacillus paracasei N1115 and the gamma-aminobutyric acid only;
(2) according to the invention, by adding lactobacillus paracasei N1115 bacterial powder with a reasonable proportion, the lactobacillus paracasei N1115 bacterial powder has good acid resistance and cholate resistance, has a good intestinal colonization effect, is propagated with animal bifidobacterium and bifidobacterium lactis in the intestinal tract in a large quantity, inhibits intestinal pathogenic bacteria, changes the pH value of the intestinal tract, stimulates intestinal peristalsis and increases the humidity of fecal mass, thereby playing a role in accelerating the feces to be discharged out of the body, and has better effects of lubricating the intestinal tract, relaxing bowels and relieving constipation compared with the effect of independently using the lactobacillus paracasei N1115 bacterial powder;
(3) according to the invention, the lavender extract is obtained by a secondary extraction process, and then the lavender extract with a reasonable addition ratio is matched with other components, so that the effects of antibiosis, anti-inflammation, spleen and stomach strengthening and immunity improvement of the lavender extract are fully exerted; the lavender extract is subjected to secondary extraction, so that the extraction rate is high and the economic benefit is good;
(4) according to the preparation method, the raw goat milk is subjected to primary filtration, degassing and secondary filtration, so that the effect of removing the smell of mutton is good;
the bowel-relaxing sleep-aiding goat milk powder containing the lavender extract is simple in preparation method, wide in raw material source, low in price, suitable for industrial production and used for preparing the bowel-relaxing sleep-aiding goat milk powder containing the lavender extract.
The bowel-relaxing sleep-aiding goat milk powder containing the lavender extract is suitable for adults to eat.
Drawings
The invention will be described in further detail with reference to the accompanying drawings and specific embodiments;
FIG. 1 is a graph showing the results of the small intestine propulsion experiments in control group, constipation model group, positive control group, experiment group 1 and experiment group 2 in example 7;
FIG. 2 is a graph showing the results of the first-pellet black stool time in the mouse defecation experiments of the control group, constipation model group, positive control group, experiment group 1 and experiment group 2 in example 7;
FIG. 3 is a graph showing the results of the moisture content of mouse feces in the control group, constipation model group, positive control group, experiment group 1 and experiment group 2 mouse feces experiments in example 7;
FIG. 4 is a graph showing the results of the sleep time experiments for sodium pentobarbital in CG group, EG1 group and EG2 group in example 8;
FIG. 5 is a graph showing the results of the sleep latency experiments for sodium barbiturate in CG group, EG1 group and EG2 group in example 8.
Detailed Description
The present invention is further illustrated by the following specific examples, which are to be construed as merely illustrative, and not limitative of the remainder of the disclosure.
Examples 1-6 preparation method of laxative sleep-aiding goat milk powder containing lavender extract
Examples 1-6 are respectively used for preparing a bowel-relaxing sleep-aiding goat milk powder containing lavender extract, which comprises the following steps in sequence, wherein the specific raw material dosage and process parameters are shown in table 1:
s1, removing the smell of raw goat milk: the method comprises the following steps of (1) primarily filtering raw goat milk by a filter with a screen mesh number of 15-28 meshes, degassing by a degassing tank under the conditions that the vacuum pressure is 85-90 bar, the inlet temperature is 78-82 ℃ and the outlet temperature is 68-72 ℃, re-filtering by a duplex filter with a screen mesh number of 20-28 meshes, and performing high-pressure spray drying by a high-pressure pump pressure of 190 bar, the inlet temperature of 150-195 ℃ and the exhaust temperature of 85-95 ℃ to obtain raw goat milk powder;
preparing a lavender extract: adding water with the mass being 8-12 times of that of fresh lavender into the fresh lavender, soaking the fresh lavender for 0.8-1.2 h, ultrasonically oscillating the mixture for 15-20 min, heating the mixture to be boiling at the low temperature of 80-90 ℃, standing the mixture for 4-6 min, and filtering the mixture by using 80-100-mesh filter cloth to obtain filtrate and filter residues;
repeating the above operations on the filter residue to obtain a second filtrate and a second filter residue;
mixing the filtrate with the filtrate of the second time, heating and concentrating at 55-65 ℃ in a water-proof manner, and spray-drying at the pump speed of a peristaltic pump of 290-300 mL/h, the air inlet temperature of 210-225 ℃ and the air exhaust temperature of 85-95 ℃ to obtain a lavender extract;
s2, sieving: sieving all the raw materials by a sieve with 110-130 meshes;
s3, mixing: uniformly mixing the sieved raw materials, namely the bowel-relaxing sleep-aiding goat milk powder (correspondingly marked as M1-M6) containing the lavender extract in the embodiments 1-6;
TABLE 1 EXAMPLES 1 TO 6 Lavender-containing Lavender extract-containing laxative sleep-aiding goat milk powder parameter table
Wherein, the bifidobacterium animalis Bb12 bacterial powder and the bifidobacterium lactis HN019 bacterial powder are general active freeze-dried bacterial powder sold in the market;
although the present invention uses the above-mentioned strain, but is not limited thereto, those skilled in the art will appreciate that all strains of the same species having the same properties can achieve the technical effects of the present invention;
the obtained defaecation sleep-aiding goat milk powder containing the lavender extract is suitable for adults to eat, and can achieve the purposes of supplementing nutrition, regulating intestinal health and improving sleep conditions after eating.
Example 7 bowel health regulating effects of laxative sleep-aiding goat milk powder containing lavender extract
Firstly, preparing an intragastric lavage sample:
control milk powder N1: control milk powder N1 was prepared according to the raw materials and preparation method of example 1, except that lavender extract was not added to the raw materials for preparing control milk powder N1; preparing a gastric lavage sample corresponding to the control milk powder N1 by dissolving 30g of milk powder in 200 ml of 50 ℃ warm water;
defaecation sleep-aiding goat milk powder containing lavender extract M1: preparing the intragastric lavage sample in the same way;
II, experimental design and results:
selecting 50 Kunming male mice with the weight of 20 +/-2 g, randomly dividing the 50 Kunming male mice into 5 groups, wherein each group comprises 10 mice, namely a control group, a constipation model group, a positive control group, an experiment group 1 and an experiment group 2, each group adopts an isometric gavage method, the dosage is 20 mL/(kg.d), corresponding samples are gavaged, each group is continuously gavage for 10d, and water is freely drunk and standard feed is freely taken;
after 10 days of gastric lavage, constructing a constipation model, preparing ink, randomly selecting 5 ink in each group to perform small intestine propulsion experiments, and calculating the small intestine propulsion rate; recording defecation conditions of other groups of mice to obtain first black excrement discharge time and calculate excrement water content;
A1) the corresponding gavage samples for each group were as follows:
firstly, perfusing distilled water into a control group;
② the constipation model group is filled with stomach distilled water;
③ the positive control group is filled with distilled water;
experimental group 1 gavage control milk powder N1;
experiment group 2 stomach-drenching laxative sleep-aiding goat milk powder M1 containing lavender extract;
A2) constructing a constipation model:
after the mice are fed with the gastric lavage for 10 days, after all the mice are fasted and fed without water for 24 hours, the constipation model is constructed by 0.025 percent of compound diphenoxylate in each group except the control group, the construction of the constipation model adopts a one-time injection administration mode, and the dosage of the compound diphenoxylate is 20ml/kg of each mouse;
A3) preparation and use of an ink sample:
preparing an ink sample: mixing Arabic gum 5g with distilled water 40mL, boiling until the mixture is clear and transparent, mixing with activated carbon powder 2.5g, boiling for 3 times, cooling, and diluting with distilled water to 50mL to obtain an ink sample.
Ink samples were used: after 0.5h of constructing a constipation model, each group of gastric lavage ink samples according to the ratio of 20 mL/kg:
ink samples for control and constipation model groups: ink samples + distilled water, 50% each;
positive control ink samples: ink samples + phenolphthalein tablet solutions, 50% each; wherein the phenolphthalein tablet can be used for treating constipation, and the phenolphthalein tablet solution is prepared by dissolving 20mg phenolphthalein tablet in 1kg distilled water;
experimental group 1 ink samples: the ink sample and the reference milk powder N1 are mixed together in a mixing mode of 50 percent respectively;
experimental group 2 ink samples: the ink sample and the bowel-relaxing sleep-aiding goat milk powder M1 containing lavender extract are mixed in the same way, wherein the mixing ratio of the ink sample to the goat milk powder M1 is 50 percent;
A4) small intestine propulsion experiments and results:
after the corresponding Chinese ink samples are perfused into the stomach, 5 Chinese ink samples are randomly selected from each group for carrying out small intestine propulsion experiments, the mice are sacrificed after 20min of perfusion, dissection is carried out, the total length of the small intestine and the distance from the pylorus at the lower end of the stomach to the front edge of ink movement are measured, and the small intestine propulsion rate is calculated according to a formula I:
the experimental result is shown in fig. 1, and as can be seen from fig. 1, the small intestine propulsion rate of the constipation model group is obviously lower than that of the control group, which indicates that the constipation model is successfully constructed; the small intestine propulsion rate of the positive control group, the experimental group 1 and the experimental group 2 is between that of the control group and that of the constipation model group, the result of the experimental group 2 is closer to that of the control group, while the positive control group and the experimental group 1 are obviously inferior to that of the experimental group 2, which shows that the intestinal tract of the mice of the experimental group 2 is more lubricated and the peristalsis is better, therefore, the defaecation and sleep-aiding goat milk powder containing the lavender extract has an outstanding defaecation effect.
A5) Mouse defecation experiments and results:
after the corresponding Chinese ink samples are perfused, feeding the remaining 25 mice in a single cage to ensure sufficient feed and water, observing the defecation condition of the mice in 6h, recording the first defecation time of each mouse, the number of 6h defecation grains and the total defecation mass, drying all the feces discharged in 6h of each mouse at the constant temperature of 65 ℃ until the feces are constant in mass, wherein the obtained data is the dry mass of the feces of the mice, and the moisture content of the feces of the mice is calculated according to a formula II:
the experimental results are shown in fig. 2 and 3, and it can be seen from fig. 2 that the black stool discharging time of the first mouse particle in the constipation model group is obviously longer than that of the control group, which indicates that the constipation model is successfully constructed; the small intestine propulsion rate of the positive control group, the experimental group 1 and the experimental group 2 is between that of the control group and that of the constipation model group, the result of the experimental group 2 is closer to that of the control group, while the positive control group and the experimental group 1 are obviously inferior to that of the experimental group 2, which shows that the intestinal tract of the mice of the experimental group 2 is more lubricated and the peristalsis is better, therefore, the bowel relaxing and sleep aiding goat milk powder containing the lavender extract has good bowel relaxing effect;
as can be seen from fig. 3, the moisture content of the feces of the positive control group, the experimental group 1 and the experimental group 2 is between the control group and the constipation model group, the result of the experimental group 2 is closer to that of the control group, while the moisture content of the feces of the positive control group and the experimental group 1 is obviously inferior to that of the experimental group 2, which indicates that the intestinal tract of the mice of the experimental group 2 is more lubricated and the feces are slightly dry and hard, so that the laxative sleep-aiding goat milk powder containing the lavender extract can effectively prevent constipation;
in conclusion, the small intestine propulsion rate and the feces water content of the experimental group 2 are higher than those of the experimental group 1 and the positive control group, and the first-particle black stool discharging time is lower than those of the experimental group 1 and the positive control group, so that compared with the experimental group 1 and the positive control group, the experimental group 2 has better performance in regulating intestinal tracts and relaxing bowel, namely the lactobacillus paracasei N1115, the gamma-aminobutyric acid and the lavender extract are synergistic, so that the laxative sleep-aiding goat milk powder containing the lavender extract has outstanding effects of lubricating the intestinal tracts and relieving constipation, and can regulate the intestinal tract health.
Example 8 sleep-aiding action of laxative sleep-aiding goat milk powder containing lavender extract
Selecting 36 Kunming male mice with the weight of 20 +/-2 g, randomly dividing the 36 Kunming male mice into 3 groups, wherein each group comprises 12 mice, namely a control group-CG group, an experimental group-EG 1 group and an EG2 group, each group adopts an equal-volume intragastric perfusion method, the dosage is 20 mL/(kg. d), and each group is perfused with corresponding samples for 30 days by continuous intragastric perfusion, and during the period, the mice freely drink water and freely eat standard feeds;
after 30 days of gastric lavage, randomly selecting 6 mice from each group for carrying out pentobarbital sodium sleep time experiments, and recording the sleep time of the mice; carrying out barbiturate sodium sleep latency experiments on the other groups of mice, and recording the sleep latency;
B1) the corresponding gavage samples for each group were as follows:
(I) CG group intragastric distilled water;
(II) EG1 group gavage control milk powder N1, the preparation method is the same as example 7;
(III) EG2 group of defaecating sleep-aiding goat milk powder M1 containing lavender extract by intragastric gavage, the preparation method is the same as above;
B2) pentobarbital sodium sleeping time experiments and results:
after 20min after the corresponding sample of the last gastric lavage, randomly selecting 6 mice from each group to perform the pentobarbital sodium sleep time experiment, intraperitoneally injecting pentobarbital sodium into each group of mice according to the dosage of 50mg/kg bw, wherein the injection amount is 0.2mL/20g bw, taking the disappearance of righting reflex of the mice as a sleep judgment index, recording the condition that the pentobarbital sodium of each group affects the sleep time of the mice, and if the sleep time of the mice of the experimental group is prolonged compared with that of the control group, judging that the experimental result is positive.
The results are shown in figure 4, the EG1 group has no significant difference (P < 0.05) from the CG group, the EG2 group has significant difference (P < 0.05) from the CG group, the sleep time of the EG2 group is obviously prolonged compared with the CG group, namely, the test result of the sleep time of sodium pentobarbital is positive, which indicates that the lactobacillus paracasei N1115 and the gamma-aminobutyric acid are synergistic. Therefore, the bowel-relaxing sleep-aiding goat milk powder containing the lavender extract can obviously prolong the sleep time of a mouse;
B3) barbiturate sodium sleep latency period experiment and results:
after 20min of the last time of perfusing the corresponding sample, carrying out a barbiturate sleep latency period experiment on the other groups of mice which are not subjected to the pentobarbital sodium sleep time experiment, carrying out intraperitoneal injection of barbital sodium at a dose of 280mg/kg bw on the mice of each group, wherein the injection amount is 0.1mL/kg bw, the disappearance of the righting reflex of the mice is used as a sleep-entering judgment standard for more than 60s, and the time from the injection of the barbital sodium to the disappearance of the righting reflex of the mice is used as a sleep latency period, so that whether the sleep latency period of the barbital sodium injection mice can be shortened or not in the comparative experiment group is judged, and if yes, the experiment result is judged to be positive.
The experimental result is shown in fig. 5, the EG1 group has no significant difference (P is less than 0.05) from the CG group, the EG2 group has significant difference (P is less than 0.05) from the CG group, the sleep latency time of the EG2 group mice is obviously shortened compared with the CG group, namely the barbiturate sodium sleep latency experimental result is positive, which shows that the synergistic effect of the Lactobacillus paracasei N1115, the gamma-aminobutyric acid and the lavender extract is achieved, so the laxative sleep-aiding goat milk powder containing the lavender extract can obviously shorten the sleep latency time of the mice;
in conclusion, the EG2 group has positive results in the experiment for prolonging the sleep time of pentobarbital sodium and the experiment for the sleep latency period of barbital sodium, the tested object can be judged to have the effect of improving the sleep according to the technical specifications of health food inspection and evaluation, and the result shows that the laxative sleep-aiding goat milk powder containing the lavender extract has the effect of improving the sleep.
It should be noted that the above-mentioned embodiments are only preferred embodiments of the present invention, and are not intended to limit the present invention in other forms, and any person skilled in the art may use the above-mentioned technical content as a teaching to make changes or modifications to the equivalent embodiments with equivalent changes, but all those simple changes, equivalent changes and modifications made to the above-mentioned embodiments without departing from the technical spirit of the present invention, and still all those embodiments are within the scope of the present invention as claimed in the claims.
Claims (9)
1. The bowel-relaxing sleep-aiding goat milk powder containing the lavender extract is characterized in that raw materials for preparing active ingredients of the bowel-relaxing sleep-aiding goat milk powder comprise the following components in parts by weight:
70-90 parts of raw goat milk powder, 6.5-13.5 parts of polydextrose, 3-10 parts of lactobacillus paracasei N1115 powder, 0.001-0.005 part of gamma-aminobutyric acid, 3-7 parts of white granulated sugar, 1.5-3.5 parts of lavender extract, 0.3-0.8 part of composite essence, 0.2-0.8 part of animal bifidobacterium powder and 0.2-0.8 part of bifidobacterium lactis powder.
2. The laxative sleep-aiding goat milk powder containing lavender extract as claimed in claim 1, wherein the lactobacillus paracasei N1115 powder, the bifidobacterium animalis powder and the bifidobacterium lactis powder are all live lyophilized powder.
3. A laxative sleep-aiding goat milk powder containing lavender extract according to claim 1 or 2, wherein the total number of colonies of the Lactobacillus paracasei N1115 powder is 0.1 x 1010～1×1010CFU/g; the total number of bacterial colonies of animal Bifidobacterium powder is 0.1 × 1010～1×1010CFU/g; the total bacterial colony count of the Bifidobacterium lactis powder is 0.1 × 1010～1×1010 CFU/g。
4. The goat milk powder containing lavender extract for relaxing bowels and assisting sleep as claimed in claim 1 or 2, wherein the raw goat milk powder is obtained by primary filtering, degassing, secondary filtering and spray drying raw goat milk.
5. The laxative sleep-aiding goat milk powder containing lavender extract as claimed in claim 4, wherein the mesh number of the primary filter screen is 15-28 meshes;
in the degassing process, the vacuum pressure is 85-90 bar, the inlet temperature is 78-82 ℃, and the outlet temperature is 68-72 ℃;
the number of the refiltered screens is 20-28 meshes.
6. A laxative sleep-aiding goat milk powder containing lavender extract as claimed in claim 1, 2 or 5, wherein the preparation process of the lavender extract comprises the following steps in sequence:
soaking fresh Lavender in water, ultrasonically oscillating, heating at low temperature to boil, standing, and filtering to obtain filtrate and residue;
repeating the above operations on the filter residue to obtain a second filtrate and a second filter residue;
mixing the filtrate with the filtrate of the second time, concentrating, and spray drying to obtain Lavender extract.
7. The laxative sleep-aiding goat milk powder containing lavender extract as claimed in claim 6,
the mass ratio of the fresh lavender to the water is 1: 8-12;
the ultrasonic oscillation time is 15-20 min;
the low-temperature heating temperature is 80-90 ℃;
the standing time is 4-6 min;
the mesh number of the filter cloth for filtering is 80-100 meshes.
8. The laxative sleep-aiding goat milk powder containing lavender extract as claimed in claim 1, 2, 5 or 7, wherein the raw material is obtained by sieving, and the mesh number of the sieve is 110-130 meshes.
9. The preparation method of the laxative sleep-aiding goat milk powder containing the lavender extract as claimed in any one of claims 1 to 8, wherein the laxative sleep-aiding goat milk powder containing the lavender extract is obtained by uniformly mixing all the raw materials.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011560765.2A CN112690335A (en) | 2020-12-25 | 2020-12-25 | Defaecation and sleep aiding goat milk powder containing lavender extract and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011560765.2A CN112690335A (en) | 2020-12-25 | 2020-12-25 | Defaecation and sleep aiding goat milk powder containing lavender extract and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112690335A true CN112690335A (en) | 2021-04-23 |
Family
ID=75510465
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011560765.2A Pending CN112690335A (en) | 2020-12-25 | 2020-12-25 | Defaecation and sleep aiding goat milk powder containing lavender extract and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112690335A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105981820A (en) * | 2015-12-24 | 2016-10-05 | 合肥康龄养生科技有限公司 | Dryness-moistening sleep-improving honeyed sheep's milk and production method thereof |
| CN108157515A (en) * | 2018-03-09 | 2018-06-15 | 北京素维生物科技有限公司 | A kind of health low fat dairy products and its preparation process |
| CN110024869A (en) * | 2019-05-29 | 2019-07-19 | 湖北咸宁向阳湖兴兴奶业有限公司 | A kind of probiotics fruit sheep milk powder |
| CN110235946A (en) * | 2019-06-05 | 2019-09-17 | 汉济生物科技（武汉）有限公司 | A kind of build up health improves the nutrient formulation goat milk powder of sleep |
| CN111631265A (en) * | 2020-05-22 | 2020-09-08 | 石家庄君乐宝乳业有限公司 | Milk powder for improving sleep disorder of children and preparation method thereof |
-
2020
- 2020-12-25 CN CN202011560765.2A patent/CN112690335A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105981820A (en) * | 2015-12-24 | 2016-10-05 | 合肥康龄养生科技有限公司 | Dryness-moistening sleep-improving honeyed sheep's milk and production method thereof |
| CN108157515A (en) * | 2018-03-09 | 2018-06-15 | 北京素维生物科技有限公司 | A kind of health low fat dairy products and its preparation process |
| CN110024869A (en) * | 2019-05-29 | 2019-07-19 | 湖北咸宁向阳湖兴兴奶业有限公司 | A kind of probiotics fruit sheep milk powder |
| CN110235946A (en) * | 2019-06-05 | 2019-09-17 | 汉济生物科技（武汉）有限公司 | A kind of build up health improves the nutrient formulation goat milk powder of sleep |
| CN111631265A (en) * | 2020-05-22 | 2020-09-08 | 石家庄君乐宝乳业有限公司 | Milk powder for improving sleep disorder of children and preparation method thereof |
Non-Patent Citations (3)
| Title |
|---|
| 三采文化: "《茶饮养生事典》", 30 April 2005, 汕头大学出版社 * |
| 张雪飞，等: "《药物制剂技术》", 31 August 2020, 世界图书出版广东有限公司 * |
| 谷鸣: "《乳品工程师实用技术手册》", 31 January 2009, 中国轻工业出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109123295B (en) | Probiotic solid beverage and preparation method thereof | |
| CN105995976A (en) | Integrated enzyme powder having effects of reducing fat and losing weight and application thereof | |
| CN106420847B (en) | Composition for assisting in protecting gastric mucosa and/or relieving gastrectasia and microecological preparation thereof | |
| CN114848685B (en) | Antiallergic probiotic composition, application thereof and probiotic traditional Chinese medicine fermentation product | |
| CN104351586A (en) | Cattle mixed feed and preparation method thereof | |
| CN111035014A (en) | Probiotic preparation and preparation method thereof | |
| CN111972670A (en) | Composition for relaxing bowel, solid beverage and application | |
| CN107496850A (en) | A kind of formula for adjusting enteral microecological formulation and application | |
| CN105767587A (en) | Traditional Chinese medicine microecological preparation for improving laying hen performance and preparation method of traditional Chinese medicine microecological preparation for improving laying hen performance | |
| CN105079450A (en) | Probiotics traditional Chinese medicine preparation for relieving yin-deficiency type constipation of elder people and preparing method and application of probiotics traditional Chinese medicine preparation | |
| CN109528814B (en) | Microecological preparation of lactobacillus fermented astragalus membranaceus as well as preparation method and application of microecological preparation | |
| CN110521785A (en) | Probiotics fermention functional food and its preparation | |
| CN113907191A (en) | Traditional Chinese medicine biological fermentation feed, preparation method and application thereof | |
| CN112602778A (en) | Laxative sleep-aiding milk powder containing lactobacillus paracasei N1115 and preparation method thereof | |
| TWI744028B (en) | Prebiotic composition for promoting growth of clostridium butyricum and uses thereof | |
| CN113575963A (en) | Oligosaccharide probiotic composition and preparation method thereof | |
| CN108938789A (en) | A kind of more bacterium combination formulations of the adjusting intestinal microecology containing xylo-oligosaccharide | |
| CN102919956B (en) | Nutrient solution capable of nursing human digestive system and preparation method thereof | |
| CN116158490A (en) | A feed additive rich in stachyose extract and Bacillus licheniformis | |
| CN112690335A (en) | Defaecation and sleep aiding goat milk powder containing lavender extract and preparation method thereof | |
| CN114586844B (en) | Durian yoghourt capable of reducing blood fat and relaxing bowel and preparation method thereof | |
| CN110801488A (en) | Combined prebiotics particle for regulating brain and intestine axis polysaccharide and preparation method and application thereof | |
| CN114158735B (en) | Probiotic composition and application thereof | |
| US11969447B2 (en) | Use of spray-dried powder derived from lactic acid bacterial strains and herbal extracts for promoting defecation | |
| CN109221697A (en) | Weaned piglets probiotic feed and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: 050000 No. 68 stone Copper Road, Hebei, Shijiazhuang Applicant after: JUNLEBAO Dairy Group Co.,Ltd. Address before: 050000 No. 68 stone Copper Road, Hebei, Shijiazhuang Applicant before: THE SHIJIAZHUANG JUNLEBAO DAIRY Co.,Ltd. |
|
| CB02 | Change of applicant information | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210423 |
|
| RJ01 | Rejection of invention patent application after publication |